Posaconazole-induced topiramate toxicity

Annals of Internal Medicine

Volumn 151, Issue 2, 2009, Pages 143-

  Marriott, Deborah ^a   Levy, Russell ^a   Doyle, Tom ^a   Ray, John ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b SydPath   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; POSACONAZOLE; TOPIRAMATE; VALPROIC ACID; VORICONAZOLE;

ADULT; ANAMNESIS; ANOREXIA; CASE REPORT; CATATONIA; DAYTIME SOMNOLENCE; DIFFERENTIAL DIAGNOSIS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPILEPSY; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; LETTER; LUNG ASPERGILLOSIS; LUNG RESECTION; MALE; PRIORITY JOURNAL; STUPOR; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

EID: 67651110352     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-151-2-200907210-00018     Document Type: Letter

References (6)

1. Wexler D, Courtney R, Richards W, Banfield C, Lim J, Laughlin M. Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study. Eur J Pharm Sci. 2004;21:645-53. [PMID: 15066665]
2. Lofton AL, Klein-Schwartz W. Evaluation of toxicity of topiramate exposures reported to poison centers. Hum Exp Toxicol. 2005;24:591-5. [PMID: 16323576]
3. Holland ML, Uetz JA, Ng KT. Automated capillary gas chromatographic assay using flame ionization detection for the determination of topiramate in plasma. J Chromatogr. 1988;433:276-81. [PMID: 3235557]
4. Contin M, Riva R, Albani F, Avoni P, Baruzzi A. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Ther Drug Monit. 2002;24:332-7. [PMID: 12021622]
5. Wikinski S. [Pharmacokinetic mechanisms underlying resistance in psychopharmacological treatment. The role of P-glycoprotein]. Vertex. 2005;16:438-41. [PMID: 16314897]
6. Latour P, Biraben A, Polard E, Bentué-Ferrer D, Beauplet A, Tribut O, et al. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both? Hum Psychopharmacol. 2004;19:193-203. [PMID: 15079854]